IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Maat Pharma Saca

CUSIP: F5888J116 | 1 institutional holders

Quarters

Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2025

Propel Bio Management, LLC94,181
0.5% of portfolio›$452.1K
StyleTurnoverLocationFiled
Propel Bio Management, LLC
94,181$452.1K0.5%ValueHighLos Angeles, CA2025-08-13